Price tracker BME primary
—
YHTI trades under the fixing modality (two daily auctions), so intraday "live" prices do not exist — the daily close is the reference. Data scraped from the official BME Growth security page once per trading day.
DCF valuation Editable assumptions
—
NAV / share (GAV − net debt)
Framework: unlevered 5-yr FCF (EBITDA − maintenance capex − remaining development capex; corporate tax 0% under the Spanish SOCIMI regime subject to conditions) discounted at WACC, terminal value = year-5 EBITDA / exit cap rate (EBITDA used as NOI proxy — flagged simplification). Equity value = EV − net debt (€172.0M, FY2025 filing). Base EBITDA €15.38M is FY2025 actual from BME-filed accounts; all growth/rate assumptions are estimates you control, not sourced figures. For a SOCIMI in portfolio ramp-up and active disposals, NAV is the primary valuation anchor; the DCF is highly sensitive to the exit cap rate. The pending OPA at €3.20 caps near-term upside if completed.